- Scribe Therapeutics files for IPO in test of appetite for early-stage biotechsScribe Therapeutics filed for a Nasdaq IPO late Thursday. The move marks a pivotal moment for the biotech and the gene editing field. The novel CRISPR enzyme developer was created nine ...Endpoints · 24d ago↗ source
- STAT+: Medicare takes another swing at 340B cuts to hospitalsReducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program.STAT · 24d ago↗ source
- STAT+: Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitalsLawmakers step into a dispute between Eli Lilly and hospitals about the 340b drug discount program.STAT · 24d ago↗ source